These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17082630)

  • 1. Bordetella bronchiseptica modulates macrophage phenotype leading to the inhibition of CD4+ T cell proliferation and the initiation of a Th17 immune response.
    Siciliano NA; Skinner JA; Yuk MH
    J Immunol; 2006 Nov; 177(10):7131-8. PubMed ID: 17082630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bordetella type III secretion and adenylate cyclase toxin synergize to drive dendritic cells into a semimature state.
    Skinner JA; Reissinger A; Shen H; Yuk MH
    J Immunol; 2004 Aug; 173(3):1934-40. PubMed ID: 15265927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bordetella type III secretion modulates dendritic cell migration resulting in immunosuppression and bacterial persistence.
    Skinner JA; Pilione MR; Shen H; Harvill ET; Yuk MH
    J Immunol; 2005 Oct; 175(7):4647-52. PubMed ID: 16177111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of Bordetella filamentous hemagglutinin and adenylate cyclase toxin to suppression and evasion of interleukin-17-mediated inflammation.
    Henderson MW; Inatsuka CS; Sheets AJ; Williams CL; Benaron DJ; Donato GM; Gray MC; Hewlett EL; Cotter PA
    Infect Immun; 2012 Jun; 80(6):2061-75. PubMed ID: 22473603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of mitogen-activated protein kinases by the Bordetella bronchiseptica Type III secretion system leads to attenuated nonclassical macrophage activation.
    Reissinger A; Skinner JA; Yuk MH
    Infect Immun; 2005 Jan; 73(1):308-16. PubMed ID: 15618167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen.
    Bottero D; Zurita ME; Gaillard ME; Bartel E; Vercellini C; Hozbor D
    Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29180369
    [No Abstract]   [Full Text] [Related]  

  • 7. The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance.
    Pilione MR; Harvill ET
    Infect Immun; 2006 Feb; 74(2):1043-9. PubMed ID: 16428751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis.
    Dunne A; Ross PJ; Pospisilova E; Masin J; Meaney A; Sutton CE; Iwakura Y; Tschopp J; Sebo P; Mills KH
    J Immunol; 2010 Aug; 185(3):1711-9. PubMed ID: 20610650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal inoculation of Bordetella bronchiseptica in mice induces long-lasting antibody and T-cell mediated immune responses.
    Gueirard P; Minoprio P; Guiso N
    Scand J Immunol; 1996 Feb; 43(2):181-92. PubMed ID: 8633198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregenomic comparative analysis between bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection.
    Harvill ET; Cotter PA; Miller JF
    Infect Immun; 1999 Nov; 67(11):6109-18. PubMed ID: 10531274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of host immune responses, induction of apoptosis and inhibition of NF-kappaB activation by the Bordetella type III secretion system.
    Yuk MH; Harvill ET; Cotter PA; Miller JF
    Mol Microbiol; 2000 Mar; 35(5):991-1004. PubMed ID: 10712682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promotion of macrophage-stimulated autoreactive T cell proliferation by interleukin-10: counteraction of macrophage suppressor activity during tumor growth.
    Alleva DG; Elgert KD
    Immunobiology; 1995 Feb; 192(3-4):155-71. PubMed ID: 7782092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor.
    Duffy MM; Pindjakova J; Hanley SA; McCarthy C; Weidhofer GA; Sweeney EM; English K; Shaw G; Murphy JM; Barry FP; Mahon BP; Belton O; Ceredig R; Griffin MD
    Eur J Immunol; 2011 Oct; 41(10):2840-51. PubMed ID: 21710489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An aromatic amino acid auxotrophic mutant of Bordetella bronchiseptica is attenuated and immunogenic in a mouse model of infection.
    McArthur JD; West NP; Cole JN; Jungnitz H; Guzmán CA; Chin J; Lehrbach PR; Djordjevic SP; Walker MJ
    FEMS Microbiol Lett; 2003 Apr; 221(1):7-16. PubMed ID: 12694904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells.
    Chen X; Howard OM; Oppenheim JJ
    J Immunol; 2007 May; 178(10):6123-9. PubMed ID: 17475838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
    Mejri N; Brossard M
    Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice.
    Kammoun H; Feunou PF; Foligne B; Debrie AS; Raze D; Mielcarek N; Locht C
    Vaccine; 2012 Aug; 30(40):5864-70. PubMed ID: 22814407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory
    Jeron A; Boehme JD; Volckmar J; Gereke M; Yevsa T; Geffers R; Guzmán CA; Schreiber J; Stegemann-Koniszewski S; Bruder D
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a genetically defined double mutant strain of Bordetella bronchiseptica lacking adenylate cyclase and type III secretion as a live vaccine.
    Mann P; Goebel E; Barbarich J; Pilione M; Kennett M; Harvill E
    Infect Immun; 2007 Jul; 75(7):3665-72. PubMed ID: 17452472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells.
    Hickey FB; Brereton CF; Mills KH
    J Leukoc Biol; 2008 Jul; 84(1):234-43. PubMed ID: 18401006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.